Pfizer Spent $4.3 Million Lobbying Government in First Quarter

Pfizer, the world’s biggest drugmaker, spent $4.3 million lobbying Congress and federal agencies in the first quarter on numerous aspects of the health care overhaul, coverage of its medicines and tax and patent issues, according to a quarterly disclosure report.
Bloomberg Businessweek